跳至主要内容
临床试验/ISRCTN33604417
ISRCTN33604417已完成1 期

Erythropoietin, magnesium sulfate and hypothermia for hypoxic-ischemic encephalopathy

Osaka City General Hospital0 个研究点目标入组 9 人开始时间: 2018年9月14日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
入组人数
9

研究概览

简要总结

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Neonates admitted to the Osaka City General Hospital Neonatal Intensive Care Unit (NICU) and diagnosed with HIE, meeting institutional criteria for therapeutic hypothermia

排除标准

  • 1. Infants older than 6 hours of birth at the time of initiation of hypothermia therapy
  • 2. Infants with major congenital abnormalities
  • 3. Infants with severe growth restriction with birth weight less than 1800 g
  • 4. Infants who were considered critically ill and unlikely to bene?t from neonatal intensive care by the attending neonatologist

研究者

相似试验

Erythropoietin, magnesium sulfate and hypothermia... | 临床试验